When should children with pediatric HIV infection receive a meningococcal conjugate vaccine?

Updated: Mar 05, 2020
  • Author: Delia M Rivera, MD; Chief Editor: Russell W Steele, MD  more...
  • Print

ACIP recommends routine immunization with meningococcal conjugate vaccine (serogroups A, C, W, and Y; Menactra or Menveo) for persons aged ≥2 months with HIV infection. HIV- infected children aged < 2 years should receive the vaccine in accordance with the age-appropriate, licensed, multidose schedule (ie, Menveo at aged 2, 4, 6, and 12 months). Persons aged ≥2 years with HIV infection who have not been previously vaccinated should receive a 2-dose primary series of MenACWY conjugate vaccine (Menactra or Menveo). Persons aged ≥2 years with HIV infection who have been previously vaccinated with 1 dose of meningococcal conjugate vaccine should receive a booster dose at the earliest opportunity, provided at least 8 weeks have elapsed since the previous dose, and then continue to receive boosters at the appropriate interval throughout life. [59]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!